A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk
Gemma Tell-Marti1,2, Joan Anton Puig-Butille3,2, Miriam Potrony1
1Dermatology Department, Melanoma Unit, Hospital Clinic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain.
Abstract:
Despite the recent identification of some novel risk genes for Alzheimer's disease (AD), the genetic etiology of late-onset Alzheimer's disease (LOAD) remains largely unknown. The inclusion of these novel risk genes to the risk attributable to the APOE gene accounts for roughly half of the total genetic variance in LOAD. The evidence indicates that undiscovered genetic factors may contribute to AD susceptibility. In the present study, we sequenced the MC1R gene in 525 Spanish LOAD patients and in 160 controls. We observed that a common MC1R variant p.V92M (rs2228479), not related to pigmentation traits, was present in 72 (14%) patients and 15 (9%) controls and confers increased risk of developing LOAD (OR: 1.99, 95% CI: 1.08-3.64, p = 0.026), especially in those patients whose genetic risk could not be explained by APOE genotype. This association remains and even increased in the subset of 69 patients with typical AD cerebrospinal fluid profile (OR: 3.40 95% CI: 1.40-8.27, p = 0.007). We did not find an association between p.V92M and age of onset of AD. Further studies are necessary to elucidate the role of MC1R in brain cells through the different MC1R pathways.
Insights
A common variant in the MC1R gene (p.V92M) increases the risk for late-onset Alzheimer's disease (LOAD), particularly in individuals without APOE gene risk factors. This finding suggests MC1R as a potential new target for LOAD research.
Area of Science:
- Neurogenetics
- Alzheimer's Disease Research
- Human Genetics
Background:
- The genetic underpinnings of late-onset Alzheimer's disease (LOAD) remain incompletely understood, with known risk genes explaining only a portion of the genetic variance.
- APOE gene variants are significant contributors to LOAD risk, but a substantial portion of genetic susceptibility is yet to be identified.
Purpose of the Study:
- To investigate the potential role of the Melanocortin 1 Receptor (MC1R) gene in the genetic etiology of LOAD.
- To identify novel genetic factors contributing to Alzheimer's disease susceptibility.
Main Methods:
- Sequencing of the MC1R gene in a cohort of 525 Spanish LOAD patients and 160 healthy controls.
- Statistical analysis to assess the association between MC1R variants and LOAD risk, including stratification by APOE genotype and cerebrospinal fluid (CSF) AD profile.
Main Results:
- A common MC1R variant, p.V92M (rs2228479), was found to be significantly associated with an increased risk of developing LOAD (OR: 1.99).
- The association was more pronounced in LOAD patients without APOE risk factors and those with a typical AD CSF profile.
- No association was observed between the MC1R p.V92M variant and the age of onset for Alzheimer's disease.
Conclusions:
- The MC1R gene, specifically the p.V92M variant, represents a potential novel genetic risk factor for late-onset Alzheimer's disease.
- Further research is warranted to elucidate the functional mechanisms of MC1R in brain cells and its pathways in the context of AD pathogenesis.
More Related Videos
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Alzheimer's Disease: Treatment
